pressurised metered dose inhalers (pMDIs) [Regulatives / Guidelines]

posted by Mahesh M – India, 2014-09-12 10:46 (4303 d 14:47 ago) – Posting: # 13493
Views: 3,816

Dear All,
My concern is about Pharmacokinetic parameters for pressurised metered dose inhalers (pMDIs) EMA submission Study.

As per the guideline http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003504.pdf
London, 22 January 2009 Doc. Ref. CPMP/EWP/4151/00 Rev. 1 Section 6.1.1 (page no10.)

“In accordance with the standard accepted methods of assessment of bioequivalence the maximum concentration (Cmax), the area under the curve (AUC) and the time to Cmax (Tmax) should be compared.”

It means Bioequivalence depends on: Cmax. AUCt and Tmax?

Regards

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
124 visitors (0 registered, 124 guests [including 18 identified bots]).
Forum time: 01:34 CEST (Europe/Vienna)

Scientists often have a naïve faith that
if only they could discover enough facts about a problem,
these facts would somehow arrange themselves
in a compelling and true solution.    Theodosius Dobzhansky

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5